Concepts (86)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperparathyroidism, Primary | 2 | 2013 | 164 | 0.440 |
Why?
|
| Cushing Syndrome | 1 | 2014 | 241 | 0.400 |
Why?
|
| Calcium | 3 | 2022 | 5794 | 0.370 |
Why?
|
| Multiple Endocrine Neoplasia Type 1 | 1 | 2011 | 44 | 0.370 |
Why?
|
| Hypertriglyceridemia | 1 | 2008 | 293 | 0.250 |
Why?
|
| Vitamin D Deficiency | 1 | 2013 | 1389 | 0.220 |
Why?
|
| Calcium Citrate | 1 | 2022 | 8 | 0.210 |
Why?
|
| Killer Cells, Natural | 4 | 2008 | 2207 | 0.210 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2008 | 716 | 0.200 |
Why?
|
| Mutation, Missense | 1 | 2011 | 2593 | 0.190 |
Why?
|
| Interleukin-12 | 1 | 2003 | 577 | 0.180 |
Why?
|
| Vitamin D | 1 | 2013 | 3311 | 0.160 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2011 | 4526 | 0.160 |
Why?
|
| Comprehension | 1 | 2022 | 641 | 0.140 |
Why?
|
| Interleukin-2 | 1 | 2003 | 1894 | 0.130 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 3 | 2008 | 808 | 0.110 |
Why?
|
| Antigens, CD1 | 3 | 2008 | 434 | 0.100 |
Why?
|
| Membrane Glycoproteins | 1 | 2003 | 3712 | 0.100 |
Why?
|
| Dietary Supplements | 1 | 2022 | 3443 | 0.080 |
Why?
|
| Monitoring, Immunologic | 1 | 2008 | 100 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2022 | 4047 | 0.070 |
Why?
|
| Complementarity Determining Regions | 1 | 2008 | 150 | 0.070 |
Why?
|
| Quality Improvement | 1 | 2022 | 3858 | 0.070 |
Why?
|
| Lymphocyte Activation | 2 | 2008 | 5496 | 0.060 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2003 | 1813 | 0.060 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2003 | 141 | 0.050 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2003 | 130 | 0.050 |
Why?
|
| Perforin | 1 | 2003 | 167 | 0.050 |
Why?
|
| DNA Mutational Analysis | 1 | 2011 | 4120 | 0.050 |
Why?
|
| Germ-Line Mutation | 1 | 2011 | 1885 | 0.050 |
Why?
|
| Receptors, Chemokine | 1 | 2003 | 652 | 0.040 |
Why?
|
| Antigens, CD1d | 3 | 2008 | 225 | 0.040 |
Why?
|
| Th1 Cells | 1 | 2003 | 1042 | 0.040 |
Why?
|
| Humans | 9 | 2022 | 768298 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2003 | 4137 | 0.030 |
Why?
|
| Adult | 3 | 2014 | 223622 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2003 | 4411 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2008 | 9261 | 0.030 |
Why?
|
| Cell Survival | 1 | 2003 | 5792 | 0.030 |
Why?
|
| Clone Cells | 2 | 2003 | 1671 | 0.020 |
Why?
|
| Female | 4 | 2014 | 397050 | 0.020 |
Why?
|
| Phytohemagglutinins | 1 | 2008 | 165 | 0.020 |
Why?
|
| Cytokines | 1 | 2003 | 7443 | 0.020 |
Why?
|
| Galactosylceramides | 1 | 2008 | 90 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 59683 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2003 | 19019 | 0.020 |
Why?
|
| Apoptosis | 1 | 2003 | 9506 | 0.020 |
Why?
|
| Middle Aged | 2 | 2013 | 223463 | 0.020 |
Why?
|
| Young Adult | 1 | 2013 | 60048 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2008 | 1065 | 0.020 |
Why?
|
| HIV-1 | 1 | 2003 | 6963 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2008 | 1157 | 0.010 |
Why?
|
| Bronchi | 1 | 2008 | 847 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2013 | 81768 | 0.010 |
Why?
|
| Male | 2 | 2013 | 364870 | 0.010 |
Why?
|
| Decidua | 1 | 2003 | 82 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 2003 | 340 | 0.010 |
Why?
|
| HIV Core Protein p24 | 1 | 2003 | 247 | 0.010 |
Why?
|
| Flow Cytometry | 2 | 2003 | 5898 | 0.010 |
Why?
|
| Spleen | 1 | 2008 | 2295 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 2003 | 446 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2008 | 1855 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2003 | 660 | 0.010 |
Why?
|
| Receptors, CCR5 | 1 | 2003 | 491 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 171544 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2008 | 3164 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2008 | 2568 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2003 | 1966 | 0.010 |
Why?
|
| Receptors, CXCR4 | 1 | 2003 | 729 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2003 | 1866 | 0.010 |
Why?
|
| Immunologic Memory | 1 | 2003 | 1374 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4584 | 0.010 |
Why?
|
| HIV Infections | 1 | 2003 | 17575 | 0.010 |
Why?
|
| Peptides | 1 | 2008 | 4352 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 1795 | 0.010 |
Why?
|
| Vaccination | 1 | 2008 | 3431 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2008 | 9563 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 1666 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2008 | 14481 | 0.010 |
Why?
|
| Liver | 1 | 2008 | 7570 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2008 | 10464 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2003 | 4647 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 22355 | 0.010 |
Why?
|
| Mice | 2 | 2008 | 82004 | 0.000 |
Why?
|
| Animals | 2 | 2008 | 169322 | 0.000 |
Why?
|
| Inflammation | 1 | 2003 | 10863 | 0.000 |
Why?
|
Concepts
(86)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_